Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03621904
What this trial is testing

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer Stage IIIEndometrial Cancer Stage IVEndometrial Cancer Recurrent
Radboud University Medical Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT05564377
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+12 more
National Cancer Institute (NCI) 2,900
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Study completedNCT01379534
What this trial is testing

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Who this might be right for
Solid Tumors and Advanced Endometrial CancerEndometrial CancerSecond-line Treatment+1 more
Novartis Pharmaceuticals 53
Early research (Phase 1)Active Not RecruitingNCT05691504
What this trial is testing

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Testing effectiveness (Phase 2)Study completedNCT03540407
What this trial is testing

Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Who this might be right for
Cervical Carcinoma Stage IICervical Carcinoma Stage IIICervical Carcinoma Stage IV+3 more
Catalysis SL 66
Testing effectiveness (Phase 2)Study completedNCT02755844
What this trial is testing

Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients

Who this might be right for
Recurrent Endometrial Cancer
Hospices Civils de Lyon 35
Testing effectiveness (Phase 2)Study completedNCT00478426
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+5 more
National Cancer Institute (NCI) 34
Early research (Phase 1)Looking for participantsNCT07593820
What this trial is testing

A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.

Who this might be right for
Metastatic Gastric CancerMetastatic Breast CancerEndometrial Cancer Metastatic
Vall d'Hebron Institute of Oncology 15
Large-scale testing (Phase 3)Looking for participantsNCT04789694
What this trial is testing

Prehabilitation in Gynaecological Cancer Patients

Who this might be right for
Ovarian CancerOvarian Cancer Stage IIIOvarian Cancer Stage IV+2 more
Charles University, Czech Republic 64
Testing effectiveness (Phase 2)UnknownNCT00905658
What this trial is testing

Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer

Who this might be right for
Cervical CancerEndometrial CancerFallopian Tube Cancer+4 more
Centre Oscar Lambret 120
Early research (Phase 1)Study completedNCT00002949
What this trial is testing

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

Who this might be right for
Bladder CancerCervical CancerEndometrial Cancer+1 more
University of Chicago 33
Testing effectiveness (Phase 2)Study completedNCT00258362
What this trial is testing

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Masonic Cancer Center, University of Minnesota 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Large-scale testing (Phase 3)Study completedNCT00002493
What this trial is testing

Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerPsychosocial Effects of Cancer and Its Treatment
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00659360
What this trial is testing

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00006089
What this trial is testing

Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaERBB2 Gene AmplificationRecurrent Uterine Corpus Carcinoma+2 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Ended earlyNCT01184053
What this trial is testing

Trisenox® in Women With Metastatic Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center 3
Early research (Phase 1)Looking for participantsNCT05039801
What this trial is testing

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Endometrial CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Malignant Solid Neoplasm+35 more
M.D. Anderson Cancer Center 54
Next Page